Basic science under threat: Lessons from the Skirball Institute
- PMID: 35245477
- DOI: 10.1016/j.cell.2022.02.008
Basic science under threat: Lessons from the Skirball Institute
Abstract
Support for basic science has been eclipsed by initiatives aimed at specific medical problems. The latest example is the dismantling of the Skirball Institute at NYU School of Medicine. Here, we reflect on the achievements and mission underlying the Skirball to gain insight into the dividends of maintaining a basic science vision within the academic enterprises.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests Agnel Sfeir is a co-founder, consultant, and shareholder in Repare Therapeutics. Gord Fishell is a co-founder, consultant, and shareholder in Regel Therapeutics. Alexander Schier, Michael Dustin, Wen-Biao Gan, Alexandra Joyner, Ruth Lehmann, David Ron, David Roth, William S. Talbot, Deborah Yelon, and Arturo Zychlinsky declare no competing interests.
MeSH terms
LinkOut - more resources
Full Text Sources